Management of Enteral Feeding Intolerance in Sepsis
When enteral feeding intolerance occurs in septic patients, use prokinetic agents as first-line therapy and consider post-pyloric feeding tube placement if intolerance persists. 1
Initial Approach to Feeding Intolerance
When a septic patient develops feeding intolerance, the Surviving Sepsis Campaign guidelines provide a clear algorithmic approach:
- Do not routinely monitor gastric residual volumes (GRVs) in septic patients receiving enteral nutrition, as this practice is not recommended 1, 2
- Measure GRVs only when clinical signs of feeding intolerance appear or in patients at high risk for aspiration 1, 2
- Continue enteral feeding unless GRV exceeds 500 mL per 6 hours 2, 3
Clinical Signs Requiring Intervention
Identify feeding intolerance by these specific clinical markers:
- Vomiting or regurgitation 2
- Abdominal distension 2, 4
- Abdominal pain or discomfort 2
- Absence of bowel sounds 2
- High gastric residual volumes (>500 mL/6 hours) 2
Step-by-Step Management Algorithm
Step 1: Pharmacologic Intervention
Administer prokinetic agents when feeding intolerance is identified 1. This is a weak recommendation with low-quality evidence, but represents the guideline-endorsed first-line approach. Erythromycin or metoclopramide are the typical agents used 2, 3.
Step 2: Feeding Route Modification
Place a post-pyloric (jejunal) feeding tube if feeding intolerance persists despite prokinetic therapy 1. This bypasses the stomach and reduces aspiration risk in patients who cannot tolerate gastric feeding 2, 3.
Step 3: Feeding Strategy Adjustment
Continue trophic/hypocaloric feeding rather than stopping feeds entirely 1. Recent evidence from NUTRIREA-2 and NUTRIREA-3 trials demonstrates that early full-dose enteral nutrition in septic shock patients receiving high-dose vasopressors increases gastrointestinal complications, including bowel ischemia 5. A "less is more" approach during the acute phase is safer.
Critical Considerations Based on Vasopressor Dose
The severity of shock directly impacts feeding tolerance:
- High vasopressor requirements increase risk of feeding intolerance and bowel ischemia 5
- Consider delaying advancement to full-dose enteral nutrition in patients on escalating vasopressors 5
- Weigh gut barrier preservation benefits against bowel ischemia risk when vasopressor doses are high 5
What NOT to Do
Avoid these common practices:
- Do not use parenteral nutrition in the first 7 days if enteral feeding is feasible, even with intolerance 1
- Do not routinely check GRVs every 4-6 hours in all patients 1, 2
- Do not stop enteral nutrition completely; instead use trophic feeds and advance as tolerated 1
- Do not add immune-modulating supplements (omega-3 fatty acids, glutamine, arginine, selenium) 1
High-Risk Populations
Certain septic patients have higher rates of feeding intolerance:
- Burn patients with sepsis have the highest risk (35% develop intolerance) and worse outcomes when intolerance occurs 4, 6
- Gastrointestinal admission diagnoses increase odds of intolerance by 45% 4
- Patients with impaired consciousness or neurological disorders affecting swallowing 2
- Patients in prone positioning 2
Clinical Impact and Monitoring
Feeding intolerance in sepsis has significant consequences:
- Associated with 10% reduction in enteral nutrition delivery 4
- Increases mortality hazard by 1.5-fold once intolerance occurs 4
- Correlates with longer ICU stay, fewer ventilator-free days, and higher mortality 4, 6
- Peak incidence occurs on days 4-5 of ICU admission (6% daily rate) 4
Practical Implementation
When GRV is measured and exceeds 500 mL/6 hours:
- Temporarily hold feeds and perform abdominal examination to rule out acute abdominal complications 2
- Initiate prokinetic therapy immediately 2, 3
- Resume trophic feeds once acute issues are excluded 2
- Advance to post-pyloric feeding if intolerance persists 2, 3
The evidence consistently supports continuing some form of enteral nutrition rather than complete cessation, as gut barrier function preservation remains important even in septic shock 5. However, the dose and timing must be carefully balanced against the patient's hemodynamic status and vasopressor requirements.